Willing and able to provide written informed consent and privacy authorization for the release of personal health information.
NOTE: Privacy authorization may be either included in the informed consent or obtained separately.
Males 21 years of age and above
Histological or cytological confirmed prostate adenocarcinoma from TRUS biopsy, radical prostatectomy or TURP Or Documented histopathology or cytopathology of prostate adenocarcinoma from a biopsy of a metastatic site Or Metastatic disease typical of prostate cancer (i.e., involving bone or pelvic lymph nodes or para-aortic lymph nodes) AND a serum concentration of PSA \>20ng/mL at the time of initial prostate cancer diagnosis
No previous diagnosis of a second, non-prostate malignancy that requires additional systemic therapy except cancer in situ of bladder and basal cell cancer of skin
Clareo Health | International Registry for Men With Advanced Prostate Cancer (IRONMAN)
